The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

Biopharmaceutical Contract Manufacturing Market Biopharmaceutical Contract Manufacturing Learn how outsourcing trends in biopharma m ...

The front-of-package labels could help consumers identify how ingredients in foods can be a part of a healthy diet.

Cattle produce more methane than any other livestock. Methane, a greenhouse gas, traps heat, which warms the Earth. It is far ...

BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

Advancements in technology and AI have paved the way for the creation of hyper-realistic, fake pornographic content, known as deepfakes, which can portray someone doing something that never happened.

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business ...

But why wait for disaster when you can improve your cash flow strategy today? This article explores setting realistic cash flow targets to ensure financial health and growth. Ready? Time to dig in.

On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) nutrition labeling (“proposed rule”).